Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Martin Cannon"'
Autor:
Steven J Conrad, Tahseen Raza, Erich A Peterson, Jason Liem, Richard Connor, Bernice Nounamo, Martin Cannon, Jia Liu
Publikováno v:
PLoS Pathogens, Vol 18, Iss 9, p e1010316 (2022)
The evolutionarily successful poxviruses possess effective and diverse strategies to circumvent or overcome host defense mechanisms. Poxviruses encode many immunoregulatory proteins to evade host immunity to establish a productive infection and have
Externí odkaz:
https://doaj.org/article/aeb4fe02497b47818c7d1537834555c9
Publikováno v:
Molecular Therapy: Oncolytics, Vol 6, Iss C, Pp 90-99 (2017)
A therapeutic approach to improve treatment outcome of ovarian cancer (OC) in patients is urgently needed. Myxoma virus (MYXV) is a candidate oncolytic virus that infects to eliminate OC cells. We found that in vitro MYXV treatment enhances cisplatin
Externí odkaz:
https://doaj.org/article/ab6fb02875c44f618cf67acb4cafe1a5
Autor:
Maurizio Chiriva-Internati, Yuefei Yu, Leonardo Mirandola, Marjorie R Jenkins, Caroline Chapman, Martin Cannon, Everardo Cobos, W Martin Kast
Publikováno v:
PLoS ONE, Vol 5, Iss 5, p e10471 (2010)
Sperm protein (Sp17) is an attractive target for ovarian cancer (OC) vaccines because of its over-expression in primary as well as in metastatic lesions, at all stages of the disease. Our studies suggest that a Sp17-based vaccine can induce an enduri
Externí odkaz:
https://doaj.org/article/290cae5621bf487d844342e3b44417c1
Publikováno v:
MedEdPublish. 9:165
This article was migrated. The article was not marked as recommended. The disruptive influence of the novel Coronavirus Disease 2019 (COVID-19) pandemic was felt worldwide, shutting down global activities and with it standard medical educational proc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47170471189526515af5cb82973635be
https://doi.org/10.15694/mep.2020.000165.1
https://doi.org/10.15694/mep.2020.000165.1
Autor:
Hannah E. Goyne, Martin Cannon
Publikováno v:
Cancer Therapeutic Targets ISBN: 9781461466130
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72b8c993b4b73f50c7642b19dc898736
https://doi.org/10.1007/978-1-4419-0717-2_62
https://doi.org/10.1007/978-1-4419-0717-2_62
Autor:
Maurizio Chiriva-Internati, Leonardo Mirandola, Marjorie Jenkins, Martin Cannon, Everardo Cobos, W. Martin Kast
Publikováno v:
Cancer Vaccines: From Research to Clinical Practice ISBN: 1841848301
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f74f24147e1c96da43ddb5a5831c3b5
https://doi.org/10.3109/9781841848303.009
https://doi.org/10.3109/9781841848303.009
Autor:
Maurizio Chiriva, Yuefei Yu, Leonardo Mirandola, Marjorie Jenkins, Caroline Chapman, Martin Cannon, Everardo Cobos, W. Martin Kast
Publikováno v:
The Journal of Immunology. 184:95.7-95.7
Sperm protein (Sp17) is an attractive target for cancer vaccines because of its over-expression in primary and metastatic ovarian cancer (OC). Our studies suggest that a Sp17-based vaccine can induce an enduring defense against OC development in C57B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4036dcaba5e56e74f067faf37fc6f44
https://doi.org/10.4049/jimmunol.184.supp.95.7
https://doi.org/10.4049/jimmunol.184.supp.95.7
Autor:
Yuefei Yu, Petra Pilgrim, Wei Zhou, Nicoletta Gagliano, E. Eldo Frezza, Marjorie Jenkins, Jon A. Weidanz, Joseph Lustgarten, Martin Cannon, Klaus Bumm, Everardo Cobos, W. Martin Kast, Maurizio Chiriva-Internati
Publikováno v:
Viral Immunology; Dec2008, Vol. 21 Issue 4, p435-442, 8p